Hypoglycemia

The FDA approved an allogenic pancreatic islet cellular therapy for adults with type 1 diabetes who struggled to achieve their target HbA1c due to repeated episodes of severe hypoglycemia, according to an agency press release.

The FDA has approved new oral therapies for children with type 2 diabetes — empagliflozin and a combination of empagliflozin and metformin hydrochloride — for the first time in more than 20 years.

People with type 2 diabetes who spend more time in glycemic range have lower risks for major adverse cardiovascular events, severe hypoglycemia and microvascular events, according to a post hoc analysis of the DEVOTE trial.

CHICAGO — Children with diabetes and their caregivers use a wide variety of continuous glucose monitoring alarm settings, and usage may differ based on the child’s age, according to a presenter at ENDO 2023.

People with type 1 diabetes using a hybrid closed-loop insulin delivery system are less likely to experience severe hypoglycemia than nonusers, according to study data.

Fewer people with diabetes filled glucagon prescriptions in 2021 compared with 2011, though increases were seen among those with type 1 diabetes and adults with a history of severe hypoglycemia, according to study data.

Researchers highlighted challenges with continuous glucose monitoring devices, including trouble interpreting results, device adhesion and smartphone access, among adults aged 50 to 85 years with type 1 or type 2 diabetes.

A strong correlation exists between time below range of 54 mg/dL and time below range of 70 mg/dL, though the difference between the two values varies based on continuous glucose monitoring type, according to study data.

GLP-1 receptor agonists may reduce the number of postprandial hypoglycemia episodes after bariatric surgery, but more research is needed to guide use in practice, according to a systematic review published in Obesity.

Switching to intermittent-scanned continuous glucose monitors with low glucose alarms reduced hypoglycemia frequency among middle-aged adults with type 1 diabetes, researchers reported.